pS2 protein detected by immunohistochemistry in archival primary breast cancer: Prognostic value and long-term follow-up in 219 patients

Oncology Reports

Volumn 3, Issue 4, 1996, Pages 759-764

  Tutschek, Boris ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

archival tissue; breast cancer; immunohistochemistry; prognostic factor; pS2 protein

Indexed keywords

ESTROGEN RECEPTOR; ONCOPROTEIN; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0029953657     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Mon K, Fujii R, Kida M, Ohta M and Hayashi K: Identification of a polypeptide secreted by human breast cancer cells (MCF-7) as the human estrogen-responsive gene (pS2) product. Biochem Biophys Res Commun 155: 366-372, 1988.
2. Masiakowski P, Breathnach R, Bloch J, Cannon F, Krust A and Chambon P: Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 10: 7895-7903, 1982.
3. Pichon MF and Milgrom E: Clinical significance of the estrogen regulated pS2 protein in mammary tumors. Crit Rev Oncol Hematol 15: 13-21, 1993.